CNSAC LifePipe®: Integrating Portable PEP Support Into Daily COPD Care Pathways for Dynamic Hyperinflation
For many adults with chronic obstructive pulmonary disease (COPD), breathlessness is not confined to clinical assessments or acute exacerbations—it emerges during routine daily activities such as walking, climbing stairs, or performing household tasks. In these real-life situations, managing expiration becomes a practical challenge, highlighting the importance of breathing support strategies that extend beyond structured clinical settings.
COPD, Dynamic Hyperinflation, and Breathing Control During Activity
COPD is characterized by persistent airflow limitation, airway instability, and impaired expiratory mechanics. One of the most clinically relevant functional phenomena in COPD—particularly during physical activity—is dynamic hyperinflation, which results from incomplete lung emptying during expiration.
Dynamic hyperinflation leads to increased end-expiratory lung volume, diaphragmatic flattening, and increased work of breathing, contributing to exertional dyspnea and reduced activity tolerance. Clinical and physiotherapy-oriented respiratory guidelines, including those aligned with ERS and GOLD frameworks, emphasize breathing control strategies as adjunctive, non-pharmacological components of comprehensive COPD management [1–3].
The Clinical Problem: Dynamic Hyperinflation in Everyday COPD Care
Dynamic hyperinflation represents a common and clinically relevant functional limitation in chronic obstructive airway disease, occurring predominantly during everyday physical activity rather than at rest. In routine outpatient and primary care settings, large patient populations are affected, with specialist and primary care structures collectively managing millions of patients with COPD or asthma, many of whom experience activity-related breathlessness linked to expiratory airflow limitation during routine daily tasks.
Although pursed-lip breathing (PLB) is widely recommended as a non-pharmacological breathing control strategy, its consistent application during daily-life exertion remains challenging. Effective use requires sustained concentration and coordination, which are often difficult to maintain during physical activity or episodes of acute dyspnea. Consequently, a persistent gap exists between clinically taught breathing techniques and their practical implementation in real-world, unsupervised settings where dynamic hyperinflation most frequently occurs.
Operational Impact: Gaps in Ambulatory and Home-Based Respiratory Support
From a healthcare delivery and workflow perspective, COPD care frequently transitions from structured clinical environments to unsupervised home and everyday-life settings, , where a broad and heterogeneous patient population is affected. Clinical observations from respiratory therapy practice indicate that a substantial proportion of patients with chronic obstructive pulmonary disease (COPD), particularly those classified as GOLD stages 3 and 4, experience exertional dyspnea during activities of daily living such as walking, dressing, and light household tasks. This reflects advanced airflow limitation, dynamic hyperinflation, and impaired gas exchange, which together reduce ventilatory reserve and exercise tolerance. These real-world findings underscore the clinical importance of effective oxygen delivery and breathing support during ambulation and low-intensity physical activity to maintain functional capacity and adherence to prescribed therapy.
Despite this widespread need, many conventional positive expiratory pressure (PEP) devices remain optimized for stationary or session-based use, limiting their applicability during spontaneous or activity-associated dyspnea.
Common operational challenges include:
- Limited portability of conventional PEP systems
- Multi-component designs requiring setup and handling
- Reduced patient acceptance when devices interfere with mobility
- Missed opportunities to support controlled expiration during exertion
These factors may reduce the real-world effectiveness of otherwise guideline-aligned breathing strategies.
Mitigation Strategy: Low-Level PEP Support During Daily Activity
Physiologically, maintaining a low and stable positive expiratory pressure during expiration may help support airway patency and promote more complete lung emptying. This mechanism is consistent with the underlying principles of PLB and PEP-based respiratory therapy devices [2,4,5]. In this context, PEP has been characterized as a flexible adjunctive modality that may be applied beyond structured therapy sessions to support breathing control during activity, without replacing standard pharmacological management [6].
Clinical guidelines recognize breathing control interventions as supportive measures that may help patients manage dyspnea during activity. Importantly, such interventions are considered adjunctive and do not replace pharmacological therapy or disease-modifying treatments [1–3].
Product Integration: CNSAC LifePipe® Within Daily-Life COPD Workflows
CNSAC LifePipe® is a portable, non-powered respiratory therapy device designed to support controlled exhalation based on the PEP principle during daily activities. It is intended for adult patients with COPD (particularly GOLD stages 3 and 4), including those who experience dynamic hyperinflation, in home or ambulatory settings.
Intended Use and Design Characteristics
- Designed to support controlled expiration during daily activities such as walking or light exertion
- Non-invasive, drug-free respiratory support accessory
- Hands-free use enabled through a wearable design
- Fixed internal geometry with no adjustment or calibration required
CNSAC LifePipe® is intended to complement existing COPD management strategies by facilitating breathing control in situations where traditional techniques may be difficult to apply consistently.
Material, Safety, and Regulatory Context
- CE MDR–approved medical device
- FDA-registered respiratory support accessory
- Single-patient use, non-sterile
- No electronics, power source, or software components
CNSAC LifePipe® does not claim to treat COPD or modify disease progression.
Practical Implementation Considerations in Clinical and Home-Care Settings
Patient Selection Considerations
CNSAC LifePipe® may be considered for adult COPD patients who:
- Experience activity-related dyspnea associated with dynamic hyperinflation
- Are ambulatory and active during daily routines
- Have received education on breathing techniques such as PLB
- Require respiratory support outside continuous clinical supervision
Final patient selection and clinical decision-making remain the responsibility of the treating healthcare professional.
Integration into care pathways
From a workflow perspective, CNSAC LifePipe® may be positioned as:
- A complementary tool within pulmonary rehabilitation and breathing education programs
- A portable aid supporting breathing control during daily-life exertion
- A continuity solution bridging clinic-based instruction and home use
Minimal training and intuitive handling support patient autonomy and acceptance. Patient-reported feedback collected during real-world observational use suggests favorable usability during daily activities. These observations are descriptive and do not constitute claims of clinical efficacy.
Summary
Dynamic hyperinflation remains a clinically relevant contributor to exertional dyspnea and functional limitation in COPD, particularly during everyday activities. While breathing control strategies such as pursed-lip breathing are supported by clinical guidance, their consistent application outside supervised settings is often limited by real-world constraints.
CNSAC LifePipe® is designed to translate estaCblished principles of PEP-supported exhalation into a portable, activity-compatible format intended for use during daily life. By aligning with recognized respiratory therapy concepts and addressing practical workflow gaps between clinic-based instruction and home use, it represents a complementary option within comprehensive daily-life COPD management strategies.
Healthcare providers, distributors, and procurement teams seeking non-invasive respiratory support solutions aligned with real-life COPD workflows may request additional technical documentation, regulatory information, and implementation guidance for CNSAC LifePipe®.
References
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of COPD. Latest update.
- European Respiratory Society (ERS). Non-pharmacological management of COPD: physiotherapy and breathing techniques.
- Nici L, ZuWallack R, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med.
- Holland AE, Hill CJ, Jones AY, McDonald CF. Breathing exercises for COPD. Cochrane Database of Systematic Reviews.
- O’Donnell DE, Elbehairy AF, Webb KA. Mechanisms of dyspnea in COPD and the role of dynamic hyperinflation. European Respiratory Journal.
6. Volsko TA. Applications of positive expiratory pressure in spontaneous breathing: why, when and how? Breathe (European Respiratory Society). 2025.